HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Piramal Pharma Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: May 23, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 247.1 as of 23 May 10:38.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 840.79 crore on March 2020 to ₹ 3693 crore on March 2024 . This represents a CAGR of 34.45% over 5 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 724.31 crore as compare to the Dec '24 revenue of ₹ 690.01 crore. This represent the growth of 4.97% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 148.91 crore as compare to the Dec '24 ebitda of ₹ 147.8 crore. This represent the growth of 0.75% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 43.09 crore over 8 quarters. This represents a CAGR of 59.21% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007.
  • The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
  • It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen spurts after turnaround Q4 outcome

Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-ta...

Read more

22 May 2025 12:16

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 21 ...

Read more

17 May 2025 14:39

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

News

Dishman Carbogen Amcis allots NCDs aggregating Rs 50 cr

Dishman Carbogen Amcis has allotted 5,000 Rated, Listed, Senior, Secured, Redeemable, Taxa...

Read more

26 Mar 2025 12:35

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

08 Mar 2025 10:27

Piramal Pharma Ltd News Hub

News

Piramal Pharma allots 35 lakh equity shares under ESOP

Piramal Pharma has allotted 35 lakh equity shares under ESOP on 21 May 2025. Consequent to...

Read more

21 May 2025 15:37

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

News

Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA

According to the company's exchange filing, the US FDA conducted a general Good Manufactur...

Read more

12 May 2025 15:39

News

Piramal Pharma to conduct board meeting

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 14 May 2025...

Read more

30 Apr 2025 10:45

News

Piramal Pharma's Telangana unit starts production of general anesthesia drug Sevoflurane

This was achieved by creating capacity for Sevoflurane manufacture at the Digwal facility ...

Read more

02 Apr 2025 11:25

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Piramal Pharma Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,839 Cr while Market cap of Piramal Pharma Ltd is 27,356 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd?

As of May 23, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹244.9. On the other hand, Piramal Pharma Ltd stock price is INR ₹206.35.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions